Also trades as: PMCUF (OTC) · $vol 0M
PME.AX ASX
Pro Medicus Limited
1W: -2.9%
1M: -9.3%
3M: -25.8%
YTD: -6.7%
1Y: -47.2%
3Y: +117.3%
5Y: +160.6%
A$159.56 ($110.92)
+3.18 (+2.03%)
Weekly Expected Move ±3.3%
A$146
A$151
A$156
A$162
A$167
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$137M
+22.6% ▲
5Y CAGR: +28.5%
Capital Expenditures
$444K
+94.0% ▲
5Y CAGR: -43.5%
Free Cash Flow
$136M
+30.9% ▲
5Y CAGR: +34.1%
Dividends Paid
$65M
-31.9% ▼
Buybacks
$10M
-29.1% ▼
Net Change in Cash
$39M
-17.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $44M | $61M | $0 | $0 | $265M |
| Depreciation & Amort. | $7M | $8M | $9M | $0 | $8M |
| Stock-Based Comp. | $32K | $1M | $0 | $0 | $0 |
| Change in Working Capital | $9M | -$6M | -$8M | -$13M | $33M |
| Other Non-Cash Items | $18M | $30M | $87M | $124M | -$170M |
| Operating Cash Flow | $62M | $65M | $87M | $111M | $137M |
| — Investing Activities — | |||||
| Capital Expenditures | -$9M | -$6M | -$7M | -$439K | -$9M |
| Acquisitions (Net) | $17M | $7M | $0 | $0 | $0 |
| Investment Purchases | -$15M | -$21M | -$46M | -$33M | -$42M |
| Investment Sales | $6M | $18M | $39M | $30M | $29M |
| Other Investing | -$17M | -$7M | -$64M | -$3M | $0 |
| Investing Cash Flow | -$18M | -$10M | -$78M | -$7M | -$21M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | -$4M | -$845K | -$3M | -$8M | -$10M |
| Dividends Paid | -$19M | -$26M | -$37M | -$49M | -$65M |
| Other Financing | -$509K | -$574K | -$518K | -$651K | -$631K |
| Financing Cash Flow | -$23M | -$28M | -$40M | -$58M | -$76M |
| Net Change in Cash | $22M | $28M | -$31M | $47M | $39M |
| Cash End of Period | $64M | $91M | $60M | $107M | $146M |
| Free Cash Flow | $53M | $58M | $80M | $104M | $136M |